Khiron Life Sciences Corp. KHRNF KHRN announced the pricing of its marketed public offering. Pursuant to the offering, the company will issue units of the company at a price of CA$0.05 ($0.036) per unit. Each unit will consist of one common share of the company and one common share purchase warrant of the company, with each unit warrant being exercisable to acquire one common share at an exercise price of CA0.08 for a period of 24 months following the closing date of the offering.
The size of the offering will be determined in the context of the market. The offering will be conducted on a best efforts agency basis by Canaccord Genuity Corp., as agent and sole bookrunner.
The agent will be granted an option to purchase up to an additional 15% of the units offered at the offering price for a period of 30 days following and including the closing date of the offering. The over-allotment option may be exercised by the agent to acquire units, unit shares and/or unit warrants.
The offering is being made in each of the provinces of Canada except Québec, and in the United States on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended.
The Offering is now expected to close on or about April 4, 2023, subject to the satisfaction of customary closing conditions and the receipt of regulatory approvals, including the approval of the TSXV. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or specific terms of the offering.
Price Action
Khiron shares were trading 13.04% lower at $0.04 per share at the time of writing Friday morning.
Benzinga's Cannabis Capital Conference Is Back
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.
Photo: Benzinga edit with photos by Stefan Balaz on Shutterstock and Peter Pike on Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.